New program aims to help cancer survivors kick the habit and ease pain
NCT ID NCT06029907
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 33 times
Summary
This pilot study tested a program for cancer survivors who smoke and have pain. Participants received behavioral support and the medication varenicline (Chantix) to help them quit smoking and manage pain. The study involved 19 people and focused on whether the program was feasible and helpful.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Duke University Health System
Durham, North Carolina, 27710, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
varenicline (Chantix)
What this could lead to
If successful, this program could offer a practical way for cancer survivors to quit smoking and manage pain at the same time.
What could go wrong
This is a very small pilot study with only 19 participants, so results may not apply to everyone. The program may not work better than standard care.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.